Openbookopenbook
Equity
Todos MedicalĀ Ltd(TOMDF)
USD --+0.00%
Reward44Moderate
Risk90High
šŸ“Š75%Data
Revenue growing 90% YoY
TOMDF
+0.0 Ā· +0.00%
USD Ā· PINK
Todos MedicalĀ Ltd | Healthcare
Speculative Momentum
Market Cap:21304
ā„¹ļø
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ā„¹ļø
Risk Rating
90
High
Risk Assessment
ā„¹ļø

Educational tool only ā€“ Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ā„¹ļø Educational tool only Ā· More
Limited data coverage
We don't have enough public data on TOMDF to score it reliably yet ā€” Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock ā€” scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have ā€” try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Todos MedicalĀ Ltd?

, a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States.

TOMDF Ā· Verdict

Moderate reward Ā· high risk

TOMDF has limited near-term tailwinds ā€” volatility and balance sheet weigh on the model output.

Based on 88% data coverage

TOMDF Ā· Verdict

Whatā€™s working & what to watch

Watchouts 5

  • Volatility5/100

    Weak vs peers

  • Balance sheet6/100

    Current ratio 0.20

  • Cash flow16/100

    -36% free-cash-flow margin

  • Profitability28/100

    -325% net margin Ā· 0% ROE

  • Growth41/100

    Earnings +36.6% CAGR

Model-based scoring. For information only ā€” not financial advice.

What is Todos MedicalĀ Ltd?

, a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 21.30K.

Financial Highlights

Investment Breakdown

šŸ“ˆ Growth
Revenue and earnings growing steadily, indicating improving operating performance.
šŸ’° Profitability
Thin or inconsistent margins weigh on earnings quality.
āš ļø Risk
Elevated volatility implies higher downside and expectation risk.
šŸ’ø Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high ā€” this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap21.30K
P/E RatioN/A
Dividend YieldN/A
52 Week HighN/A
52 Week LowN/A
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding2B
No. of EmployeesN/A
IndustryDiagnostics & Research
ExchangePINK
Beta9.922
CurrencyUSD
Websitetodosmedical.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

Ā© 2026 Openbook Analytics Ltd Ā· Company No.Ā SC843579 Ā· Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.